Guizhou Yibai Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600594.SS

Guizhou Yibai Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2023: USD 82.63 M

Guizhou Yibai Pharmaceutical Co., Ltd. Inventory is USD 82.63 M for the year ending December 31, 2023, a -8.78% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Guizhou Yibai Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2022 was USD 90.58 M, a 3.77% change year over year.
Guizhou Yibai Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2021 was USD 87.29 M, a 14.33% change year over year.
Guizhou Yibai Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2020 was USD 76.35 M, a 29.50% change year over year.
Guizhou Yibai Pharmaceutical Co., Ltd. Inventory for the year ending December 31, 2019 was USD 58.96 M, a 12.96% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

Shanghai Stock Exchange: 600594.SS

Guizhou Yibai Pharmaceutical Co., Ltd.

CEO	Ms. Ya Qi Dou
IPO Date	March 23, 2004
Location	China
Headquarters	No. 220-1, Baiyun Avenue
Employees	5,509
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China.

Key trends

Past 5 years